Nanoconjugate based on polymalic acid for tumor targeting
- 30 January 2008
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 171 (2), 195-203
- https://doi.org/10.1016/j.cbi.2007.01.015
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesisAngiogenesis, 2006
- Intracellular drug delivery by sulfatide-mediated liposomes to gliomasJournal of Controlled Release, 2006
- Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modificationJournal of Controlled Release, 2006
- 99mTc-Labeled Cyclic RGDfK Dimer: Initial Evaluation for SPECT Imaging of Glioma Integrin αvβ3 ExpressionBioconjugate Chemistry, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Nanostructurated Complexes of Poly(β,l-malate) and Cationic Surfactants: Synthesis, Characterization and Structural AspectsBiomacromolecules, 2005
- Low-Molecular-Weight Poly(α-methylβ,L-malate) of Microbial Origin: Synthesis and CrystallizationMacromolecular Bioscience, 2005
- Invention and commercialization in optical bioimagingNature Biotechnology, 2003
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal of Cancer, 1995
- In Vivo Fate of End-Chain Radiolabelled Poly(β-malic acid), a Water-Soluble Biodegradable Drug CarrierJournal of Bioactive and Compatible Polymers, 1990